首页> 外文期刊>International Journal of Clinical and Experimental Pathology >Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma
【24h】

Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma

机译:切除肝门胆管癌患者术前血清CA19-9水平是独立的预后因素

获取原文
           

摘要

To investigate the appropriate cutoff point of CA19-9 for prognosis and other potential prognostic factors that may affect survival of patients with hilar cholangiocarcinoma (HC) after radical surgery. 168 patients who had undergone radical surgery for hilar cholangiocarcinoma and resultant macroscopic curative resection (R0 and R1) were discreetly selected for analyses. Categorized versions were used in univariate model to determine the appropriate cutoff point of CA19-9. CA19-9 and other clinicopathologic factors were analyzed for influence on survival by univariate and multivariate methods. The strongest univariate predictor among the categorized preoperative CA19-9 measures was CA19-9 less than 150 IU/L (P = 0.000). In univariate analysis, tumor size, Bismuth-Corlette classification, portal vein invasion, Lymph node metastasis, resection margin and preoperative CA19-9 levels were identified as significant prognostic factors. In multivariable analysis, lymph node metastasis, resection margin and preoperative CA19-9 levels were independent prognostic factors. our results demonstrated that preoperative CA19-9 levels was also an independent prognostic factor for hilar cholangiocarcinoma, and the most discriminative cutoff point of CA19-9 for prognosis proved to be at 150 U/ml.
机译:调查CA19-9的适当分界点,以考虑预后及可能影响肝门胆管癌(HC)患者根治性手术后生存的其他预后因素。精心选择了168例因肺门胆管癌接受了根治性手术并进行宏观根治性切除(R0和R1)的患者进行分析。在单变量模型中使用分类版本来确定CA19-9的适当临界点。通过单变量和多变量方法分析了CA19-9和其他临床病理因素对生存的影响。在分类的术前CA19-9措施中,最强的单变量预测因子是CA19-9低于150 IU / L(P = 0.000)。在单因素分析中,肿瘤大小,Bistuth-Corlette分类,门静脉侵犯,淋巴结转移,切除切缘和术前CA19-9水平被确定为重要的预后因素。在多变量分析中,淋巴结转移,切除切缘和术前CA19-9水平是独立的预后因素。我们的结果表明,术前CA19-9水平也是肝门胆管癌的独立预后因素,而CA19-9的最高判别临界点为150 U / ml。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号